Building a Global Ecosystem Research Infrastructure to Address Global Grand Challenges for Macrosystem Ecology

The development of several large-, "continental"-scale ecosystem research infrastructures over recent decades has provided a unique opportunity in the history of ecological science. The Global Ecosystem Research Infrastructure (GERI) is an integrated network of analogous, but independent, site-based ecosystem research infrastructures (ERI) dedicated to better understand the function and change of indicator ecosystems across global biomes. Bringing together these ERIs, harmonizing their respective data and reducing uncertainties enables broader cross-continental ecological research. It will also enhance the research community capabilities to address current and anticipate future global scale ecological challenges. Moreover, increasing the international capabilities of these ERIs goes beyond their original design intent, and is an unexpected added value of these large national investments. Here, we identify specific global grand challenge areas and research trends to advance the ecological frontiers across continents that can be addressed through the federation of these cross-continental-scale ERIs.Peer reviewe

Reanalysis in Earth System Science: Towards Terrestrial Ecosystem Reanalysis

A reanalysis is a physically consistent set of optimally merged simulated model states and historical observational data, using data assimilation. High computational costs for modelled processes and assimilation algorithms has led to Earth system specific reanalysis products for the atmosphere, the ocean and the land separately. Recent developments include the advanced uncertainty quantification and the generation of biogeochemical reanalysis for land and ocean. Here, we review atmospheric and oceanic reanalyses, and more in detail biogeochemical ocean and terrestrial reanalyses. In particular, we identify land surface, hydrologic and carbon cycle reanalyses which are nowadays produced in targeted projects for very specific purposes. Although a future joint reanalysis of land surface, hydrologic and carbon processes represents an analysis of important ecosystem variables, biotic ecosystem variables are assimilated only to a very limited extent. Continuous data sets of ecosystem variables are needed to explore biotic-abiotic interactions and the response of ecosystems to global change. Based on the review of existing achievements, we identify five major steps required to develop terrestrial ecosystem reanalysis to deliver continuous data streams on ecosystem dynamics

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.

OBJECTIVES: To provide an accurate, web-based tool for stratifying patients with atrial fibrillation to facilitate decisions on the potential benefits/risks of anticoagulation, based on mortality, stroke and bleeding risks. DESIGN: The new tool was developed, using stepwise regression, for all and then applied to lower risk patients. C-statistics were compared with CHA2DS2-VASc using 30-fold cross-validation to control for overfitting. External validation was undertaken in an independent dataset, Outcome Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). PARTICIPANTS: Data from 39 898 patients enrolled in the prospective GARFIELD-AF registry provided the basis for deriving and validating an integrated risk tool to predict stroke risk, mortality and bleeding risk. RESULTS: The discriminatory value of the GARFIELD-AF risk model was superior to CHA2DS2-VASc for patients with or without anticoagulation. C-statistics (95% CI) for all-cause mortality, ischaemic stroke/systemic embolism and haemorrhagic stroke/major bleeding (treated patients) were: 0.77 (0.76 to 0.78), 0.69 (0.67 to 0.71) and 0.66 (0.62 to 0.69), respectively, for the GARFIELD-AF risk models, and 0.66 (0.64-0.67), 0.64 (0.61-0.66) and 0.64 (0.61-0.68), respectively, for CHA2DS2-VASc (or HAS-BLED for bleeding). In very low to low risk patients (CHA2DS2-VASc 0 or 1 (men) and 1 or 2 (women)), the CHA2DS2-VASc and HAS-BLED (for bleeding) scores offered weak discriminatory value for mortality, stroke/systemic embolism and major bleeding. C-statistics for the GARFIELD-AF risk tool were 0.69 (0.64 to 0.75), 0.65 (0.56 to 0.73) and 0.60 (0.47 to 0.73) for each end point, respectively, versus 0.50 (0.45 to 0.55), 0.59 (0.50 to 0.67) and 0.55 (0.53 to 0.56) for CHA2DS2-VASc (or HAS-BLED for bleeding). Upon validation in the ORBIT-AF population, C-statistics showed that the GARFIELD-AF risk tool was effective for predicting 1-year all-cause mortality using the full and simplified model for all-cause mortality: C-statistics 0.75 (0.73 to 0.77) and 0.75 (0.73 to 0.77), respectively, and for predicting for any stroke or systemic embolism over 1 year, C-statistics 0.68 (0.62 to 0.74). CONCLUSIONS: Performance of the GARFIELD-AF risk tool was superior to CHA2DS2-VASc in predicting stroke and mortality and superior to HAS-BLED for bleeding, overall and in lower risk patients. The GARFIELD-AF tool has the potential for incorporation in routine electronic systems, and for the first time, permits simultaneous evaluation of ischaemic stroke, mortality and bleeding risks. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier for GARFIELD-AF (NCT01090362) and for ORBIT-AF (NCT01165710)

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.

AIMS: The relationship between outcomes and time after diagnosis for patients with non-valvular atrial fibrillation (NVAF) is poorly defined, especially beyond the first year. METHODS AND RESULTS: GARFIELD-AF is an ongoing, global observational study of adults with newly diagnosed NVAF. Two-year outcomes of 17 162 patients prospectively enrolled in GARFIELD-AF were analysed in light of baseline characteristics, risk profiles for stroke/systemic embolism (SE), and antithrombotic therapy. The mean (standard deviation) age was 69.8 (11.4) years, 43.8% were women, and the mean CHA2DS2-VASc score was 3.3 (1.6); 60.8% of patients were prescribed anticoagulant therapy with/without antiplatelet (AP) therapy, 27.4% AP monotherapy, and 11.8% no antithrombotic therapy. At 2-year follow-up, all-cause mortality, stroke/SE, and major bleeding had occurred at a rate (95% confidence interval) of 3.83 (3.62; 4.05), 1.25 (1.13; 1.38), and 0.70 (0.62; 0.81) per 100 person-years, respectively. Rates for all three major events were highest during the first 4 months. Congestive heart failure, acute coronary syndromes, sudden/unwitnessed death, malignancy, respiratory failure, and infection/sepsis accounted for 65% of all known causes of death and strokes for <10%. Anticoagulant treatment was associated with a 35% lower risk of death. CONCLUSION: The most frequent of the three major outcome measures was death, whose most common causes are not known to be significantly influenced by anticoagulation. This suggests that a more comprehensive approach to the management of NVAF may be needed to improve outcome. This could include, in addition to anticoagulation, interventions targeting modifiable, cause-specific risk factors for death. CLINICAL TRIAL REGISTRATION: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

ALTER-Net, a long-term biodiversity, ecosystem and awareness research network. – Year 7

Van Dijk, J., Ulateig, G. Terrasson, D., De Blust, G., Sier, A., Braat, L., Kanka, R., Mirtl, M., Török, K., Furman, E., Kertész, M., & Stadler, J. 2011. ALTER-Net, a long-term biodiversity, ecosystem and awareness research network – Year 7. – NINA Report 685, 83 pp. During year seven of ALTER-Net several activities have proven the added value of having the network and together with the partner contributions that have been spent on our network activities (i.e. Common Research Programme, Communication & Knowledge Transfer, Common Training Programme, Data Sharing Policy, Long Term Ecological Research - LTER, LifeWatch, InterDisciplinary Research - IDR and Multi-Site Experiment) we have further guaranteed the durable integration of European biodiversity research. In Vienna ALTER-Net arranged the workshop on our Common Research Strategy (CRS) which was very successful. During the workshop it was agreed to have a regularly updated CRS by means of an annual research priority meeting with Council, young researchers and stakeholders prior to setting our yearly activities. The ALTER-Net website and the enews letters are highly appreciated and with regular updates of ALTER-Net activities, biodiversity events, job vacancies, funding possibilities members of the website stay informed about what is going on. Both the LTER-Europe secretariat and the team working on the ALTER-Net/LTER-data infrastructure at UBA have been responsible for running the LTEREurope network and improving the data infrastructure of LTER-Europe respectively. For our work on InterDisciplinary Research ALTER-Net organized two very successful events; a conference in Vienna (Biodiversity and Ecosystem Services, what is the link between the two?) and a workshop in Paris (Ecosystem Services and Governance). Both outcomes are combined in a policy document (one long version for the research community and other interested persons and one short version especially for policy makers). Also this year ALTER-Net organized its Summer School which was again a great success and one of our most visible outputs of the network together with the work on Multi-Site Experiment II. Both the ALTER-Net Summer School and the Multi-Site Experiment involve many ALTER-Net partners and prove the added value of the network. The impressive list of 45 ongoing collaborative projects and 8 new joint proposals of which 3 are on the EU funding list from 2011, as well as the 198 publications with two or more ALTER-Net partners show that the fundament of the network is in place and the network is functioning. KEY WORDS : biodiversity, ecosystem, awareness, Interdisciplinary research, research network, NØKKELORD : biomangfold, økosystem, formidling, tverrfaglig kunnskap, forskningsnettver

Effects of aspect and altitude on carbon cycling processes in a temperate mountain forest catchment

Context Varying altitudes and aspects within small distances are typically found in mountainous areas. Such a complex topography complicates the accurate quantification of forest C dynamics at larger scales. Objectives We determined the effects of altitude and aspect on forest C cycling in a typical, mountainous catchment in the Northern Limestone Alps. Methods Forest C pools and fluxes were measured along two altitudinal gradients (650-900 m a.s.l.) at south-west (SW) and north-east (NE) facing slopes. Net ecosystem production (NEP) was estimated using a biometric approach combining field measurements of aboveground biomass and soil CO2 efflux (SR) with allometric functions, root:shoot ratios and empirical SR modeling. Results NEP was higher at the SW facing slope (6.60 ? 3.01 t C ha-1 year-1), when compared to the NE facing slope (4.36 ? 2.61 t C ha-1 year-1). SR was higher at the SW facing slope too, balancing out any difference in NEP between aspects (NE: 1.30 ? 3.23 t C ha-1 year-1, SW: 1.65 ? 3.34 t C ha-1 year-1). Soil organic C stocks significantly decreased with altitude. Forest NPP and NEP did not show clear altitudinal trends within the catchment. Conclusions Under current climate conditions, altitude and aspect adversely affect C sequestering and releasing processes, resulting in a relatively uniform forest NEP in the catchment. Hence, including detailed climatic and soil conditions, which are driven by altitude and aspect, will unlikely improve forest NEP estimates at the scale of the studied catchment. In a future climate, however, shifts in temperature and precipitation may disproportionally affect forest C cycling at the southward slopes through increased water limitation

Effects of aspect and altitude on carbon cycling processes in a temperate mountain forest catchment

Context: Varying altitudes and aspects within small distances are typically found in mountainous areas. Such a complex topography complicates the accurate quantification of forest C dynamics at larger scales. Objectives We determined the effects of altitude and aspect on forest C cycling in a typical, mountainous catchment in the Northern Limestone Alps. Methods Forest C pools and fluxes were measured along two altitudinal gradients (650-900 m a.s.l.) at south-west (SW) and north-east (NE) facing slopes. Net ecosystem production (NEP) was estimated using a biometric approach combining field measurements of aboveground biomass and soil CO2 efflux (SR) with allometric functions, root:shoot ratios and empirical SR modeling. Results NEP was higher at the SW facing slope (6.60 ? 3.01 t C ha-1 year-1), when compared to the NE facing slope (4.36 ? 2.61 t C ha-1 year-1). SR was higher at the SW facing slope too, balancing out any difference in NEP between aspects (NE: 1.30 ? 3.23 t C ha-1 year-1, SW: 1.65 ? 3.34 t C ha-1 year-1). Soil organic C stocks significantly decreased with altitude. Forest NPP and NEP did not show clear altitudinal trends within the catchment. Conclusions Under current climate conditions, altitude and aspect adversely affect C sequestering and releasing processes, resulting in a relatively uniform forest NEP in the catchment. Hence, including detailed climatic and soil conditions, which are driven by altitude and aspect, will unlikely improve forest NEP estimates at the scale of the studied catchment. In a future climate, however, shifts in temperature and precipitation may disproportionally affect forest C cycling at the southward slopes through increased water limitation